If you are visiting our site to join our GSK PBG Plus (Market Share) Agreement to receive best upfront pricing, please note you must first be a member of Physicians’ Alliance of America. If you are not yet a member, please click here to complete our membership form.
To participate in the GSK PBG Plus Option 1 Agreement, your practice would need to agree to primarily use the GSK portfolio of vaccines in your practice. Those using the pediatric portfolio will primarily use the following vaccines: Pediarix, Infanrix, Kinrix, Engerix-B Pediatric, Havrix Pediatric, Rotarix, Boostrix, Menveo and Bexsero or their component vaccines, and do not use competing products. Those practices not using the pediatric portfolio of vaccines will agree to feature Boostrix, Engerix-B Adult, Havrix Adult, Twinrix, Menveo and Bexsero (and not purchase competing vaccines). Practices are agreeing to make GSK purchases for these vaccines at least 80% of their total purchase of such vaccines.
To request to be linked to this agreement or you would like to know about GSK PBG Plus Options 2 & 3, call us at 866-348-9780 or email email@example.com.
For over ten years we have partnered with this industry leader as they "strive to improve the quality of human life by enabling people to do more, feel better and live longer." GSK has, for several years now, had a strong pipeline for new products in the industry. Learn more at www.gsk.com. GSK offers the following vaccines: